Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Authors : Lopes Renato D RD; Alexander John H JH; Al-Khatib Sana M SM; Ansell Jack J; Diaz Raphael R; Easton J Donald JD; Gersh Bernard J BJ; Granger Christopher B CB; Hanna Michael M; Horowitz John J; Hylek Elaine M EM; McMurray John J V JJ; Verheugt Freek W A FW; Wallentin Lars L; ;
Affiliations : Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Journal : Am. Heart J. (2010)
Related Links: Pubmed | Publisher website
Does dabigatran improve stroke-prevention in atrial fibrillation?
Authors : Eikelboom J W JW; Wallentin L L; Yusuf S S; Ezekowitz M D MD; Reilly P A PA; Brueckmann M M; Clemens A A; Connolly S J SJ;
Affiliations : Population Health Research Institute, McMaster University, Hamilton, Canada.
Journal : N/A (2010)
Related Links: Pubmed | Publisher website
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
Authors : Lopes Renato D RD; Starr Aijing A; Pieper Carl F CF; Al-Khatib Sana M SM; Newby L Kristin LK; Mehta Rajendra H RH; Van de Werf Frans F; Mahaffey Kenneth W KW; Armstrong Paul W PW; Harrington Robert A RA; White Harvey D HD; Wallentin Lars L; Granger Christopher B CB;
Affiliations : Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Journal : Am. J. Med. (2010)
Related Links: Pubmed | Publisher website
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Authors : Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
Affiliations : Correspondence to Michael D. Ezekowitz, MBChB, DPhil, FRCP, Lankenau Institute for Medical Research, 100 Lancaster Ave, Suite G36, Wynnewood, PA 19096. E-mail ezekowitzm@mlhs.org
Journal : Circulation (2010)
Related Links: Pubmed | Publisher website
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;
Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : Circulation (2011)
Related Links: Pubmed | Publisher website
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;
Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : N/A (2011)
Related Links: Pubmed | Publisher website
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Authors : Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J;
Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : Circulation (2011)
Related Links: Pubmed | Publisher website
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Authors : Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
Affiliations : Correspondence to Michael D. Ezekowitz, MBChB, DPhil, FRCP, Lankenau Institute for Medical Research, 100 Lancaster Ave, Suite G36, Wynnewood, PA 19096. E-mail ezekowitzm@mlhs.org
Journal : Circulation (2011)
Related Links: Pubmed | Publisher website
"Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy
Authors : Jonas Oldgren, MD, PhD; Ulrika Andersson, MSc; Stuart J. Connolly, MD; Michael D. Ezekowitz, MB, ChB; Stefan H. Hohnloser, MD; Paul A. Reilly, PhD; Dragos Vinereanu, MD, PhD; Agneta Siegbahn, MD, PhD; Salim Yusuf, MD, PhD;
Affiliations : " Correspondence to Ziad Hijazi, MD, Uppsala Clinical Research Center, Dag Hammarskjölds väg 14B, 1st floor, SE- 752 37 Uppsala, Sweden. E-mail Ziad.hijazi@ucr.uu.se "
Journal : Original Articles (2012)
Related Links: Pubmed | Publisher website
Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
Authors : Hohnloser, MD; Jonas Oldgren, MD; Sean Yang, PhD; Lars Wallentin, MD; Michael Ezekowitz, MD; Paul Reilly, MD; John Eikelboom, MD; Martina Brueckmann, MD; Salim Yusuf, MD;
Affiliations : Correspondence to Stefan H. Hohnloser, MD, FACC, FESC, FHRS, Division of Clinical Electrophysiology, J.W. Goethe University Hospital, Theodor-Stern-Kai 7, D 60590 Frankfurt, Germany. E-mail Hohnloser@em.uni-frankfurt.de
Journal : Original Articles (2012)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...